MedCity INVEST | National Healthcare Investing Event

Loading Events
This event has passed.

MedCity INVEST is the premier national healthcare investing conference based in the Midwest.

For well over a decade, this conference has united active investors with corporate business development executives to syndicate investment opportunities with promising start-ups in the biopharma, diagnostics, medical device, health IT, and health services sectors.

Join us at the Four Seasons Hotel Chicago May 1-2, 2018 to hear from innovative investors, prominent industry players and 40+ startup companies—highlighting opportunities to invest in the most elite companies offering innovative approaches or trying to solve some of healthcare’s greatest challenges.

Last year MedCity’s annual INVEST conference in the Windy City attracted around 350 attendees attracted by strong programming where we discussed everything from how tech companies have plans for clinical disruption to the evolving payer-provider collaboration.

This year, too, MedCity is discussing exciting technologies such as blockchain and AI along with newer trends in healthcare where upstart payers are working with established health systems to create a new framework for population health.

Jan. 30 is the last day to save $500, so please register.

Here’s the complete agenda for our 2018 conference.

What will you see when you get to Chicago, May 1-2. For one, the hottest startups.

  • Pear Therapeutics’ Everett Crossland, who heads up market access and reimbursement will discuss how investors are seeking well-thought out reimbursement models from entrepreneurs. If you didn’t know, Pear is one of the nine companies, including Apple, Verily, and Roche that is part of FDA’s pilot program on digital health.
  • Fabien Beckers, CEO of Arterys, will discuss how the company’s medical imaging AI cloud, which is FDA-approved to boot, is bringing this new technology into the clinical workspace.is
  • Dawn Barry, president and co-founder of Luna DNA, will talk about a new application of blockchain in healthcare – the first and only genomic and medical research knowledge database.
  • Thorsten Wirkes, vice president of Oscar Health, will be there to talk about the partnership with Cleveland Clinic to provide health insurance to the providers’ patient population.

You will meet venture capitalists too – Renee Ryan, vice president of venture investments, at Johnson & Johnson Innovation – JJDC; Jessica Zeaske, director of healthcare investments, GE Ventures, and Nicole Walker, partner at Baird Capital and many more. Some of these VCs will judge the INVEST Pitch Perfect startup competition – more than 40 startups selected from different healthcare sectors – biopharma, health IT, diagnostics, devices and health services who will get up ons stage to become the best of INVEST.

But INVEST is not just about new startups eager to transform healthcare and the financiers who take bets on their vision.

The conference will also discuss issues that are core to healthcare today. For instance, the issue of drug pricing and whether that will affect the way companies engage in innovation. John Flavin, a biotech VC and the head of the Polsky Center Entrepreneurship and Innovation at the University of Chicago will bring his perspectives on that panel as well as Shehnaaz Suliman, senior vice president of, business development and strategy at Theravance Biopharma, who was formerly a Roche executive.

Digital health is a staple at most conferences these days, but we are looking at this market from the point of view of scale. There are so many ideas but entrepreneurs seem to going from one pilot to another without seeing adoption. How do they break this cycle? What do providers want? Hear that perspective from Raj Khandwalla, a cardiologist at Cedars Sinai Medical Care with a keen interest in digital medicine.


 WHO ATTENDS

Who Attends MedCity INVEST

audience-breakdown